HKPD · Cellyan Biotechnology Co., Ltd
Market Cap
$6.16M
Shares
49.32M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.13
Open$0.12
Day$0.12–0.13
52W close$0.12–1.74
Avg vol 30d6.1M
Short int199K · 0.4% float · 1.8d
Short vol28%
DataJan 2025–Sep 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-33.9%
Year over year
Operating margin
-17.8%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+48.6%
Year over year · more shares
Price change (1Y)
-91.3%
Trailing year
Short interest
0.4%
Latest settlement · 1.8 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−79%
below
Price vs 50-day avg
−66%
below
RSI (14)
22
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−70%
trailing
6-month return
−80%
trailing
YTD return
−85%
this year
Relative strength
−98%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+50% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.40% of float · ▼ -46.8% MoM · 1.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 1-yr range
Squeeze score
27
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
118%
annualized · 1-yr
Max drawdown
−93%
past year
ATR
35.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−79%
Bearish
Price vs 50-day avg
−66%
Bearish
RSI (14)
22
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+50% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.40% of float · ▼ -46.8% MoM · 1.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $2
vs 200-day avg -79%
vs 50-day avg -66%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HKPD
this stock
Cellyan Biotechnology Co., Ltd
|
$6.16M | -84.8% | — | — | 0.4% |
|
MCK
Mckesson Corp
|
$102.78B | +7.5% | +3.1% | 23.7 | 2.4% |
|
COR
Cencora, Inc.
|
$61.36B | -4.8% | +9.3% | 23.9 | 2.4% |
|
CAH
Cardinal Health Inc
|
$54.56B | +14.1% | +14.2% | — | 2.9% |
|
HSIC
Henry Schein Inc
|
$9.85B | +16.9% | +5.9% | 25.8 | 7.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
6
- % held
- 0.5%
- Net QoQ
- +182.9K sh
- Top holder
- StoneX Group Inc.
Held
Float
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HKPD | -10.7% | -70.2% | -80.3% | -62.5% | -84.8% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | -9.6% | -68.5% | -98.2% | -62.1% | -96.9% |